Mark L. Bagarazzi

2018

In 2018, Mark L. Bagarazzi earned a total compensation of $1.3M as Former Chief Medical Officer at Inovio Pharmaceuticals, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$171,238
Option Awards$358,612
Salary$448,101
Stock Awards$354,783
Other$13,154
Total$1,345,888

Bagarazzi received $448.1K in salary, accounting for 33% of the total pay in 2018.

Bagarazzi also received $171.2K in non-equity incentive plan, $358.6K in option awards, $354.8K in stock awards and $13.2K in other compensation.

Rankings

In 2018, Mark L. Bagarazzi's compensation ranked 7,692nd out of 14,244 executives tracked by ExecPay. In other words, Bagarazzi earned more than 46.0% of executives.

ClassificationRankingPercentile
All
7,692
out of 14,244
46th
Division
Manufacturing
2,991
out of 5,765
48th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
373
out of 849
56th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
212
out of 547
61st
Industry
Surgical and Medical Instruments and Apparatus
130
out of 348
63rd

Pay ratio

Mark L. Bagarazzi's Pay$1,345,888
Median Employee's Pay$118,696
Pay Ratio

11

to 1

In 2018, the annual total compensation of Mark L. Bagarazzi was $1,345,888.

The annual total compensation of the median employee at Inovio Pharmaceuticals was $118,696.

The ratio of Mark L. Bagarazzi's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on March 25, 2019.

Bagarazzi's colleagues

We found three more compensation records of executives who worked with Mark L. Bagarazzi at Inovio Pharmaceuticals in 2018.

2018

J Kim

Inovio Pharmaceuticals

Chief Executive Officer

2018

Niranjan Sardesai

Inovio Pharmaceuticals

Chief Operating Officer

2018

Peter Kies

Inovio Pharmaceuticals

Chief Financial Officer

News

You may also like